These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 23223700)

  • 1. Adult dermatomyositis: experience of a Brazilian tertiary care center.
    Souza FH; Barros TB; Levy-Neto M; Shinjo SK
    Rev Bras Reumatol; 2012 Dec; 52(6):897-902. PubMed ID: 23223700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-Jo-1 antisynthetase syndrome.
    Shinjo SK; Levy-Neto M
    Rev Bras Reumatol; 2010; 50(5):492-500. PubMed ID: 21125186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Inclusion body myositis: series of 30 cases from a Brazilian tertiary center].
    Alverne AR; Marie SK; Levy-Neto M; de Souza FH; de Carvalho MS; Shinjo SK
    Acta Reumatol Port; 2013; 38(3):179-85. PubMed ID: 24149014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. National registry of patients with juvenile idiopathic inflammatory myopathies in Hungary--clinical characteristics and disease course of 44 patients with juvenile dermatomyositis.
    Constantin T; Ponyi A; Orbán I; Molnár K; Dérfalvi B; Dicso F; Kálovics T; Müller J; Garami M; Sallai A; Balogh Z; Szalai Z; Fekete G; Dankó K
    Autoimmunity; 2006 May; 39(3):223-32. PubMed ID: 16769656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Newly diagnosed dermatomyositis in the elderly as predictor of malignancy.
    de Souza FH; Shinjo SK
    Rev Bras Reumatol; 2012 Oct; 52(5):713-21. PubMed ID: 23090371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunosuppressant treatment in refractory myositis. Our experience].
    Danieli MG; Spalletta C; Moretti R; Calabrese V; Marchetti A; Gabrielli A; Logullo F
    Recenti Prog Med; 2009 Oct; 100(10):451-7. PubMed ID: 20030167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Idiopathic pulmonary fibrosis in a referral center in Iran: are patients developing the disease at a younger age?
    Hashemi Sadraei N; Riahi T; Masjedi MR
    Arch Iran Med; 2013 Mar; 16(3):177-81. PubMed ID: 23432171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Juvenile dermatomyositis in the Nice area: a retrospective study 1991-2001].
    Jäger C; Sirvent N; Rabasse N; Soler C; Sebag F; Boutte P; Lacour JP
    Ann Dermatol Venereol; 2002 Oct; 129(10 Pt 1):1120-4. PubMed ID: 12442123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Dermatomyositis in childhood].
    Mateos González ME; López-Laso E; Gómez Reino J; Simón de las Heras R; Mateos Beato F
    An Esp Pediatr; 2000 May; 52(5):424-9. PubMed ID: 11003943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence, risk factors, and severity of herpesvirus infections in a cohort of 121 patients with primary dermatomyositis and dermatomyositis associated with a malignant neoplasm.
    Fardet L; Rybojad M; Gain M; Kettaneh A; Cherin P; Bachelez H; Dubertret L; Lebbe C; Morel P; Dupuy A
    Arch Dermatol; 2009 Aug; 145(8):889-93. PubMed ID: 19687419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pediatric dermatomyositis. Apropos of 28 cases].
    Bruguier A; Texier P; Clement MC; Dulac O; Ponsot G; Arthuis M
    Arch Fr Pediatr; 1984 Jan; 41(1):9-14. PubMed ID: 6721660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical characteristics of juvenile dermatomyositis].
    Constantin T; Ponyi A; Garami M; Gergely L; Fekete G; Dankó K
    Orv Hetil; 2003 Jun; 144(25):1245-50. PubMed ID: 12901181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous immunoglobulin for refractory cutaneous dermatomyositis: a retrospective analysis from an academic medical center.
    Femia AN; Eastham AB; Lam C; Merola JF; Qureshi AA; Vleugels RA
    J Am Acad Dermatol; 2013 Oct; 69(4):654-7. PubMed ID: 24034377
    [No Abstract]   [Full Text] [Related]  

  • 14. Influence of age at onset on the duration of treatment in idiopathic adult polymyositis and dermatomyositis.
    McKendry RJ
    Arch Intern Med; 1987 Nov; 147(11):1989-91. PubMed ID: 3675101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination antimalarials in the treatment of cutaneous dermatomyositis: a retrospective study.
    Ang GC; Werth VP
    Arch Dermatol; 2005 Jul; 141(7):855-9. PubMed ID: 16027300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rituximab for the treatment of the skin manifestations of dermatomyositis: a report of 3 cases.
    Dinh HV; McCormack C; Hall S; Prince HM
    J Am Acad Dermatol; 2007 Jan; 56(1):148-53. PubMed ID: 17097377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prognostic factors and predictive signs of malignancy in adult dermatomyositis].
    Gallais V; Crickx B; Belaich S
    Ann Dermatol Venereol; 1996; 123(11):722-6. PubMed ID: 9636749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Juvenile dermatomyositis in Thai children.
    Singalavanija S; Liamsuwan S; Limpongsanurak W; Raungsuwan S
    J Med Assoc Thai; 2001 Nov; 84(11):1527-33. PubMed ID: 11853294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ten-year experience of juvenile dermatomyositis: a retrospective study.
    Chiu SK; Yang YH; Wang LC; Chiang BL
    J Microbiol Immunol Infect; 2007 Feb; 40(1):68-73. PubMed ID: 17332910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymyositis and dermatomyositis: short term and longterm outcome, and predictive factors of prognosis.
    Marie I; Hachulla E; Hatron PY; Hellot MF; Levesque H; Devulder B; Courtois H
    J Rheumatol; 2001 Oct; 28(10):2230-7. PubMed ID: 11669162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.